EligibleTrials
Drugs & treatments › LXP1788 is administered intravenously via Port-A

LXP1788 is administered intravenously via Port-A: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1
Recruiting trials
10
Conditions studied
0
US states with sites
1
Countries

Phase breakdown

Phase 1 1

Conditions being studied

ConditionTrials
HCC - Hepatocellular Carcinoma1
Pancreas Cancer1
Pancreatic cancer1
RCC, Renal Cell Cancer1
Solid Cancers1
Solid Tumor Cancer1
Solid Tumor Malignancies, Cancer1
Solid Tumor, Unspecified, Adult1
Solid Tumors Refractory to Standard Therapy1
Solid Tumour1

Recruiting trials involving LXP1788 is administered intravenously via Port-A

Common questions

How many recruiting trials involve LXP1788 is administered intravenously via Port-A?

1 recruiting trial across 10 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.